메뉴 건너뛰기
Journal of the American College of Cardiology
Volumn 61, Issue 21, 2013, Pages 2197-2198
Niacin therapy lives for another day - Maybe?
Author keywords

[No Author keywords available]
Indexed keywords

COLESTYRAMINE; EZETIMIBE; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LAROPIPRANT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; SIMVASTATIN; TORCETRAPIB; TRIACYLGLYCEROL;
EID: 84877993864     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.01.082     Document Type: Letter
Times cited : (6)
References (11)
  • 1
    • 59049091800 scopus 로고    scopus 로고
    • The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: A new era in atherosclerosis management
    • G.A. Cardenas, C.J. Lavie, V. Cardenas, R.V. Milani, P.A. McCullough The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management Rev Cardiovasc Med 9 2008 239 258
    • (2008) Rev Cardiovasc Med , vol.9 , pp. 239-258
    • Cardenas, G.A.1    Lavie, C.J.2    Cardenas, V.3    Milani, R.V.4    McCullough, P.A.5
  • 2
    • 37449029988 scopus 로고    scopus 로고
    • Shedding light on high-density lipoprotein cholesterol: The post-ILLUMINATE era
    • C.J. Lavie, R.V. Milani Shedding light on high-density lipoprotein cholesterol: the post-ILLUMINATE era J Am Coll Cardiol 51 2008 56 58
    • (2008) J Am Coll Cardiol , vol.51 , pp. 56-58
    • Lavie, C.J.1    Milani, R.V.2
  • 3
    • 33750465522 scopus 로고    scopus 로고
    • Cholesterol ester transfer protein inhibition: The next frontier in combating coronary disease?
    • R.V. Milani, C.J. Lavie Cholesterol ester transfer protein inhibition: the next frontier in combating coronary disease? J Am Coll Cardiol 48 2006 1791 1792
    • (2006) J Am Coll Cardiol , vol.48 , pp. 1791-1792
    • Milani, R.V.1    Lavie, C.J.2
  • 4
    • 36348975228 scopus 로고    scopus 로고
    • Effects of torcetrapib in patients at high risk for coronary events
    • P.J. Barter, M. Caulifield, M. Eriksson Effects of torcetrapib in patients at high risk for coronary events N Engl J Med 357 2007 2109 2122
    • (2007) N Engl J Med , vol.357 , pp. 2109-2122
    • Barter, P.J.1    Caulifield, M.2    Eriksson, M.3
  • 5
    • 84855171302 scopus 로고    scopus 로고
    • Niacin in patients with low HDL receiving intensive statin therapy
    • W.E. Boden, J.L. Probstfield, T. Anderson Niacin in patients with low HDL receiving intensive statin therapy N Engl J Med 365 2011 2255 2267
    • (2011) N Engl J Med , vol.365 , pp. 2255-2267
    • Boden, W.E.1    Probstfield, J.L.2    Anderson, T.3
  • 6
    • 0021350001 scopus 로고
    • The Lipids Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease
    • The Lipids Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease JAMA 251 1984 351 364
    • (1984) JAMA , vol.251 , pp. 351-364
  • 7
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 8
    • 84872679028 scopus 로고    scopus 로고
    • The current state of niacin in cardiovascular disease prevention: A systematic review and meta-regression
    • P.M. Lavigne, R.H. Karas The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression J Am Coll Cardiol 61 2013 440 446
    • (2013) J Am Coll Cardiol , vol.61 , pp. 440-446
    • Lavigne, P.M.1    Karas, R.H.2
  • 10
    • 0028972026 scopus 로고
    • A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
    • S.A. Kliewer, J.M. Lenhard, T.M. Willson, I. Patel, D.C. Morris, J.M. Lehmann A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation Cell 83 1995 813 819
    • (1995) Cell , vol.83 , pp. 813-819
    • Kliewer, S.A.1    Lenhard, J.M.2    Willson, T.M.3    Patel, I.4    Morris, D.C.5    Lehmann, J.M.6
  • 11
    • 77951704587 scopus 로고    scopus 로고
    • Effects of combination lipid therapy in type 2 diabetes mellitus
    • ACCORD Study Group
    • ACCORD Study Group H.N. Ginsberg, M.B. Elam, L.C. Lovato Effects of combination lipid therapy in type 2 diabetes mellitus N Engl J Med 362 2010 1563 1574
    • (2010) N Engl J Med , vol.362 , pp. 1563-1574
    • Ginsberg, H.N.1    Elam, M.B.2    Lovato, L.C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.